Please ensure Javascript is enabled for purposes of website accessibility

PetMed Express Earnings Seem Immune to Coronavirus

By Rich Smith - May 5, 2020 at 8:30AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

But acquiring new customers remains difficult.

The coronavirus pandemic has done a number on a number of American retailers -- but PetMed Express (PETS 0.57%) is not one of them.

As the name implies, PetMed Express is in the business of selling prescription and non-prescription medicine for pets, and by all indications, business is (mostly) booming. The company's fiscal fourth-quarter 2020 earnings results, released Monday morning, showed sales up a big 15% in Q4, with profits up a more modest 9%. 

Veterinarian holding a puppy holding a stethoscope

Image source: Getty Images.

CEO Menderes Akdag confirmed that "due to COVID-19, demand has been strong for the e-commerce channel," which makes up about 85% of PetMeds' total sales, "with consumers shifting their purchases to online." The CEO notes that this "positively impacted our sales." Also helpful was that the company has apparently been lucky enough to avoid "any material disruptions in our supply chain." 

Repeat customers are remaining a loyal and profitable part of PetMed's business during the pandemic. "Reorder sales" of medicines previously bought via the service increased faster than overall sales, rising 17%. "New order sales" grew at a slower 5% rate. Customer growth was similarly slow -- up 6% year over year.

Still, this big difference between "reorder sales" and "new order sales" -- a three-fold difference in growth rates -- is curious. Management did not address the disparity, either in its earnings release or in its follow-up call with analysts. One wonders, however, if the requirement that a customer obtain a veterinarian's prescription -- and therefore visit a veterinarian to get a prescription -- before making a first order from PetMed may be hindering growth on that side of the company's business.

For as long as vet offices remain closed, or operating on restricted schedules during the pandemic, "new order sales" growth may be hard to come by.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

PetMed Express, Inc. Stock Quote
PetMed Express, Inc.
PETS
$21.16 (0.57%) $0.12

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
323%
 
S&P 500 Returns
112%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 07/06/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.